Drugs / NRT6003 Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07657273 | Jun 2026 → Dec 2027 expected | hepatocellular carcinoma | Second Affiliated Hospital of Guangzhou Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NRT6003 Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07657273 ↗ |
| Route | Other | “administered by transarterial infusion” NCT07657273 ↗ |